/PRNewswire/ Immunyx Pharma, a developer of immune modulating therapies for neutrophil based diseases, announced it has been selected to join Blue Knight, a.
COVID still climbing, with 43,815 new cases detected, but no major rise in serious cases; of 257 serious cases, there are 64 people on ventilators and a further 12 on ECMO machines
At Jerusalem’s Hadassah Hospital there is a race to open beds as cases grow, alongside relief that the new variant isn’t leaving patients gasping for air as its predecessors did